FECAL CALPROTECTIN LEVELS AFTER INDUCTION WITH ANTI-TNF AGENTS IN INFLAMMATORY BOWEL DISEASE CORRELATES WITH THE CLINICAL RESPONSE

被引：0
|
作者：
Marzo, M. [1 ]
Armuzzi, A. [1 ]
Felice, C. [1 ]
Andrisani, G. [1 ]
Sparano, L. [1 ]
Vitale, G. [1 ]
Pugliese, D. [1 ]
Papa, A. [1 ]
De Vitis, I. [1 ]
Forni, F. [1 ]
Rapaccini, G. [1 ]
Guidi, L. [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2010年 / 42卷
关键词：
D O I：
10.1016/S1590-8658(10)60336-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P.224
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [1] Fecal Calprotectin Values in Inflammatory Bowel Disease Patients After Induction Course of Anti-TNF Agents: Correlation With the Clinical Response
    Guidi, Luisa
    Marzo, Manuela
    Felice, Carla
    Andrisani, Gianluca
    Sparano, Lucia
    Vitale, Giovanna
    Pugliese, Daniela
    Papa, Alfredo
    De Vitis, Italo
    Forni, Franca
    Rapaccini, Gian Ludovico
    Armuzzi, Alessandro
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S686 - S686
  • [2] Fecal calprotectin in Inflammatory Bowel Disease treated with anti-TNF agents
    Marzo, M.
    Armuzzi, A.
    Felice, C.
    Forni, F.
    Papa, A.
    De Vitis, I
    Guidi, L.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S39 - S39
  • [3] Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
    Molander, Pauliina
    af Bjorkesten, Clas-Goran
    Mustonen, Harri
    Haapamaki, Johanna
    Vauhkonen, Matti
    Kolho, Kaija-Leena
    Farkkila, Martti
    Sipponen, Taina
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (11) : 2011 - 2017
  • [4] Factors Predicting Response to Anti-TNF Agents for Patients With Inflammatory Bowel Disease
    Yoon, Soon Man
    Haritunians, Talin
    Chhina, Sultan
    Ye, Byong Duk
    Shih, David Q.
    Vasiliauskas, Eric
    Ippoliti, Andrew
    Targan, Stephan
    Melmed, Gil Y.
    McGovern, Dermot
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S49 - S50
  • [5] Induction of antiphospholipid antibodies in patients with inflammatory bowel disease treated with anti-TNFα agents
    Robles, V.
    deGuise, C. Herrera
    Guirola, M. A.
    Borruel, N.
    Casellas, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S254 - S255
  • [6] Inflammatory bowel disease after anti-TNF drugs
    Hamilton, Louise
    Griffin, Jane
    Dahiya, Sandeep
    Somerville, Margaret
    Stodell, Malcolm
    [J]. RHEUMATOLOGY, 2008, 47 : II18 - II18
  • [7] Investigation of the effects of anti-TNF agents on hemoglobin levels in patients with inflammatory bowel disease
    Okuyucu, Muhammed
    Avcioglu, Ufuk
    Senel, Tugba
    Ustaoglu, Muge
    [J]. MEDICINE, 2022, 101 (35) : E30118
  • [8] Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?
    Miheller, Pal
    Kiss, Lajos Sandor
    Lorinczy, Katalin
    Lakatos, Peter Laszlo
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (02) : 179 - 192
  • [9] Lower Therapeutic Response to Anti-TNF Agents in African Americans with Inflammatory Bowel Disease
    Owings, Anna H.
    Burstiner, Landen
    Royer, Amor
    Johnson, Jeshanah
    Barr, Madelyn
    Hreish, Yousef
    Bradley, Lauren
    Edwards, Kane
    Brar, Himmat
    Laird, Hannah
    Claggett, Brian
    Liu, Julia
    Glover, Sarah C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S326 - S327
  • [10] Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
    Guerra, Ivan
    Algaba, Alicia
    Lazaro Perez-Calle, Jose
    Chaparro, Maria
    Marin-Jimenez, Ignacio
    Garcia-Castellanos, Raquel
    Gonzalez-Lama, Yago
    Lopez-Sanroman, Antonio
    Mancenido, Noemi
    Martinez-Montiel, Pilar
    Quintanilla, Elvira
    Taxonera, Carlos
    Villafruela, Monica
    Romero-Mate, Alberto
    Lopez-Serrano, Pilar
    Gisbert, Javier P.
    Bermejo, Fernando
    [J]. JOURNAL OF CROHNS & COLITIS, 2012, 6 (05): : 518 - 523
12345